Anistreplase for acute coronary thrombosis.
D016255:Anistreplase; D002986:Clinical Trials as Topic; D003328:Coronary Thrombosis / Q000188:drug therapy; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy*; D010958:Plasminogen / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D013300:Streptokinase / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*
D005343:Fibrinolytic Agents; D016255:Anistreplase; D010958:Plasminogen; D013300:Streptokinase